• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

红藻氨酸受体 1 磷酸化和左旋多巴诱导的运动反应改变在半帕金森病大鼠中的持续表达。

GluR1 phosphorylation and persistent expression of levodopa-induced motor response alterations in the Hemi-Parkinsonian rat.

机构信息

Department of Neurology, Yuhuangding Hospital Affiliated To Qingdao Medical University, Yantai City, Shandong 264000, People's Republic of China.

出版信息

Neurochem Res. 2011 Jun;36(6):1135-44. doi: 10.1007/s11064-011-0461-y. Epub 2011 Apr 3.

DOI:10.1007/s11064-011-0461-y
PMID:21461922
Abstract

The phosphorylation of glutamate receptor 1 (GluR1) has been increasingly implicated in the formation and maintenance of plastic responses. To investigate molecular mechanisms that underlie the persisting alterations in motor response occurring with levodopa treatment of parkinsonian patients, we evaluated the time course of these changes in relation to the phosphorylation of GluR1 in 6-hydroxydopamine (6-OHDA) lesioned animals. Three weeks of twice-daily levodopa administration to rats shortened the duration of the rotational responses and increased the peak turning responses, which lasted at least 7 days after withdrawal of chronic levodopa treatment. The shortened response duration and increased peak turning, resembling human wearing-off fluctuations and dyskinesia, were associated with a marked increase in Ser-845 phosphorylated GluR1 (pGluR1S845) immunoreactivity in lesioned striatum in response to levodopa treatment. The time course of changes in GluR1 phosphorylation correlated with the time course of changes in motor behavior after withdrawal of chronic levodopa therapy. Our immunostaining data showed that these changes were confined to parvalbumin-positive neurons where GluR1 are exclusively expressed. Both the altered motor response and the degree of pGluR1S845 were attenuated by the intrastriatal administration of protein kinase A (PKA) inhibitor Rp-cAMPS or GluR1 antisense oligonucleotides. The results suggest that Ser-845 GluR1 phosphorylation within parvalbumin-positive neurons contributes to the persistence of the motor response alterations produced by chronic intermittent dopaminergic stimulation.

摘要

谷氨酸受体 1(GluR1)的磷酸化在可塑性反应的形成和维持中越来越受到关注。为了研究帕金森病患者左旋多巴治疗中持续发生的运动反应改变的分子机制,我们评估了这些变化与 6-羟多巴胺(6-OHDA)损伤动物中 GluR1 磷酸化的关系。连续 3 周每日两次给予大鼠左旋多巴,缩短了旋转反应的持续时间,并增加了峰值旋转反应,停药后至少 7 天仍持续存在。这种反应持续时间缩短和峰值旋转增加的现象类似于人类的“开-关”波动和运动障碍,与 Ser-845 磷酸化 GluR1(pGluR1S845)免疫反应性在损伤纹状体中对左旋多巴治疗的显著增加有关。GluR1 磷酸化的变化与慢性左旋多巴治疗停药后运动行为的变化时间进程相关。我们的免疫染色数据表明,这些变化仅限于表达 GluR1 的副肾素阳性神经元。改变运动反应和 pGluR1S845 的程度均可通过纹状体内给予蛋白激酶 A(PKA)抑制剂 Rp-cAMPS 或 GluR1 反义寡核苷酸来减轻。结果表明,副肾素阳性神经元内的 Ser-845 GluR1 磷酸化可能导致慢性间歇性多巴胺能刺激产生的运动反应改变持续存在。

相似文献

1
GluR1 phosphorylation and persistent expression of levodopa-induced motor response alterations in the Hemi-Parkinsonian rat.红藻氨酸受体 1 磷酸化和左旋多巴诱导的运动反应改变在半帕金森病大鼠中的持续表达。
Neurochem Res. 2011 Jun;36(6):1135-44. doi: 10.1007/s11064-011-0461-y. Epub 2011 Apr 3.
2
Changes in subcellular distribution and phosphorylation of GluR1 in lesioned striatum of 6-hydroxydopamine-lesioned and l-dopa-treated rats.6-羟基多巴胺损伤及左旋多巴治疗大鼠损伤纹状体中GluR1的亚细胞分布和磷酸化变化
Neurochem Res. 2006 Nov;31(11):1337-47. doi: 10.1007/s11064-006-9177-9. Epub 2006 Oct 20.
3
Cyclic AMP responsive element binding protein phosphorylation and persistent expression of levodopa-induced response alterations in unilateral nigrostriatal 6-OHDA lesioned rats.环磷酸腺苷反应元件结合蛋白磷酸化与单侧黑质纹状体6-羟基多巴胺损伤大鼠左旋多巴诱导的反应改变的持续表达。
J Neurosci Res. 2003 Jun 15;72(6):768-80. doi: 10.1002/jnr.10629.
4
Gene transfer of constitutively active protein kinase C into striatal neurons accelerates onset of levodopa-induced motor response alterations in parkinsonian rats.将组成型活性蛋白激酶C基因转移至纹状体神经元可加速帕金森病大鼠左旋多巴诱导的运动反应改变的发作。
Brain Res. 2003 May 2;971(1):18-30. doi: 10.1016/s0006-8993(03)02348-5.
5
NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats.NR2B 选择性 N-甲基-D-天冬氨酸受体拮抗剂 CP-101,606 可预防左旋多巴诱导的偏侧帕金森病大鼠运动反应改变。
Neuropharmacology. 2004 Aug;47(2):184-94. doi: 10.1016/j.neuropharm.2004.03.011.
6
Comparative effects of acute or chronic administration of levodopa to 6-OHDA-lesioned rats on the expression and phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in the striatum.左旋多巴急性或慢性给药对6-羟基多巴胺损伤大鼠纹状体中N-甲基-D-天冬氨酸受体NR1亚基表达和磷酸化的比较作用。
Neurochem Res. 2009 Aug;34(8):1513-21. doi: 10.1007/s11064-009-9939-2. Epub 2009 Mar 13.
7
Non-NMDA receptor-mediated mechanisms are involved in levodopa-induced motor response alterations in Parkinsonian rats.非NMDA受体介导的机制参与了帕金森病大鼠左旋多巴诱导的运动反应改变。
Synapse. 2000 Jun 15;36(4):267-74. doi: 10.1002/(SICI)1098-2396(20000615)36:4<267::AID-SYN3>3.0.CO;2-Y.
8
Protein kinase A inhibitor attenuates levodopa-induced motor response alterations in the hemi-parkinsonian rat.蛋白激酶A抑制剂可减轻半帕金森病大鼠左旋多巴诱导的运动反应改变。
Neurosci Lett. 1997 May 30;228(1):5-8. doi: 10.1016/s0304-3940(97)00355-8.
9
Levodopa/benserazide microspheres reduced levodopa-induced dyskinesia by downregulating phosphorylated GluR1 expression in 6-OHDA-lesioned rats.左旋多巴/苄丝肼微球通过下调6-羟基多巴胺损伤大鼠中磷酸化的GluR1表达来减轻左旋多巴诱导的异动症。
Drug Des Devel Ther. 2012;6:341-7. doi: 10.2147/DDDT.S38008. Epub 2012 Nov 20.
10
LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian rats.
Synapse. 2001 Oct;42(1):40-7. doi: 10.1002/syn.1097.

引用本文的文献

1
Postsynaptic density protein 95-regulated NR2B tyrosine phosphorylation and interactions of Fyn with NR2B in levodopa-induced dyskinesia rat models.突触后致密蛋白95调节左旋多巴诱导的异动症大鼠模型中NR2B的酪氨酸磷酸化及Fyn与NR2B的相互作用。
Drug Des Devel Ther. 2014 Dec 19;9:199-206. doi: 10.2147/DDDT.S75495. eCollection 2015.
2
Brain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies.脑形态计量学与左旋多巴诱导运动障碍的神经生物学:转化临床前神经影像学研究的现有知识和未来潜力。
Front Neurol. 2014 Jun 12;5:95. doi: 10.3389/fneur.2014.00095. eCollection 2014.
3

本文引用的文献

1
BDNF activates mTOR to regulate GluR1 expression required for memory formation.脑源性神经营养因子激活雷帕霉素靶蛋白以调节记忆形成所需的谷氨酸受体1表达。
PLoS One. 2009 Jun 23;4(6):e6007. doi: 10.1371/journal.pone.0006007.
2
Comparative effects of acute or chronic administration of levodopa to 6-OHDA-lesioned rats on the expression and phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in the striatum.左旋多巴急性或慢性给药对6-羟基多巴胺损伤大鼠纹状体中N-甲基-D-天冬氨酸受体NR1亚基表达和磷酸化的比较作用。
Neurochem Res. 2009 Aug;34(8):1513-21. doi: 10.1007/s11064-009-9939-2. Epub 2009 Mar 13.
3
Optimizing long-term therapy for Parkinson disease: levodopa, dopamine agonists, and treatment-associated dyskinesia.
Therapeutic potential of targeting glutamate receptors in Parkinson's disease.
靶向谷氨酸受体在帕金森病中的治疗潜力。
J Neural Transm (Vienna). 2014 Aug;121(8):861-80. doi: 10.1007/s00702-014-1176-4. Epub 2014 Feb 21.
4
Intrastriatal injections of KN-93 ameliorates levodopa-induced dyskinesia in a rat model of Parkinson's disease.纹状体内注射 KN-93 可改善帕金森病大鼠模型中左旋多巴诱导的运动障碍。
Neuropsychiatr Dis Treat. 2013;9:1213-20. doi: 10.2147/NDT.S45422. Epub 2013 Aug 19.
5
Targeting glutamate receptors to tackle the pathogenesis, clinical symptoms and levodopa-induced dyskinesia associated with Parkinson's disease.靶向谷氨酸受体治疗帕金森病的发病机制、临床症状和左旋多巴诱导的运动障碍。
CNS Drugs. 2012 Dec;26(12):1017-32. doi: 10.1007/s40263-012-0016-z.
优化帕金森病的长期治疗:左旋多巴、多巴胺激动剂及治疗相关的运动障碍
Clin Neuropharmacol. 2008 Jan-Feb;31(1):51-6. doi: 10.1097/WNF.0b013e318065b088.
4
Pharmacotherapy for Parkinson's disease.帕金森病的药物治疗
Pharmacotherapy. 2007 Dec;27(12 Pt 2):161S-173S. doi: 10.1592/phco.27.12part2.161S.
5
Phosphorylation of AMPA receptors: mechanisms and synaptic plasticity.AMPA 受体的磷酸化:机制与突触可塑性
Mol Neurobiol. 2005 Dec;32(3):237-49. doi: 10.1385/MN:32:3:237.
6
AMPA receptor phosphorylation during synaptic plasticity.突触可塑性过程中的AMPA受体磷酸化
Biochem Soc Trans. 2005 Dec;33(Pt 6):1354-6. doi: 10.1042/BST0331354.
7
Early administration of entacapone prevents levodopa-induced motor fluctuations in hemiparkinsonian rats.早期给予恩他卡朋可预防左旋多巴诱导的偏侧帕金森病大鼠运动波动。
Exp Neurol. 2005 Mar;192(1):184-93. doi: 10.1016/j.expneurol.2004.10.008.
8
Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory.AMPA受体GluR1亚基的磷酸化对于突触可塑性和空间记忆的保持是必需的。
Cell. 2003 Mar 7;112(5):631-43. doi: 10.1016/s0092-8674(03)00122-3.
9
AMPA receptor antagonist LY293558 reverses preproenkephalin mRNA overexpression in the striatum of 6-OHDA-lesioned-rats treated with L-dopa.AMPA受体拮抗剂LY293558可逆转用左旋多巴治疗的6-羟基多巴胺损伤大鼠纹状体中前脑啡肽原mRNA的过表达。
Eur J Neurosci. 2002 Dec;16(11):2236-40. doi: 10.1046/j.1460-9568.2002.02275.x.
10
Molecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype.表达多巴胺D5受体亚型的大鼠纹状体神经元的分子表型
Eur J Neurosci. 2002 Dec;16(11):2049-58. doi: 10.1046/j.1460-9568.2002.02280.x.